German packaging and medical equipment maker Gerresheimer reported a drop in its organic core earnings on Friday, hit by ...

A novel drug that produces a temporary coating in the small intestine could be a new strategy for weight loss—and an alternative to surgeries and GLP-1 drugs.

WeightWatchers is planning to file for bankruptcy after failing to compete against the rise of ‘quick-fix’ weight loss tools, ...

The increasing use of GLP-1 medications for weight loss is leading to significant changes in food preferences, with users ...

After massive gains in the past five years on the heels of the weight loss blockbuster Zepbound, Eli Lilly & Co (LLY) stock ...

As a large proportion of people taking medications like Mounjaro, Ozempic and Wegovy for weight loss report consuming ... Smoothie King had already seen the writing on the wall, too, and created a ...

A study from the Arkansas Agricultural Experiment Station finds that GLP-1 medications, such as Ozempic and Wegovy, are ...

Eli Lilly & Co.’s shares fell Monday morning after the Trump administration spiked a plan late last week to pay for obesity drugs for Medicare patients.

The Trump administration rejected a proposed rule to allow Medicare to cover blockbuster obesity drugs for weight loss alone ...

With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help ...

I dined at Jason Atherton’s new project and it almost joined my top meals ever. Here are three of the best restaurants in London ...